Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care (NQ: TNDM )

31.91 +0.54 (+1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
36 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal... 
Via Benzinga
Medtronic Hits FDA Snag For Diabetes Business — Leading A Rival To Pop
The FDA sent Medtronic a warning letter regarding its diabetes business. 
Via Investor's Business Daily
Tandem Diabetes Care Announces Expansion of Senior Leadership Team
From Tandem Diabetes Care, Inc.
Via Business Wire
Analyzing Tandem Diabetes Care's Unusual Options Activity
On Thursday, shares of Tandem Diabetes Care (NASDAQ:TNDM)... 
Via Benzinga
2 Unstoppable Growth Stocks That Could Double Your Money in 5 Years (or Less)
These companies have a history of crushing the market. 
Via The Motley Fool
Tandem Diabetes Care to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
Jim Cramer Shares His Thoughts On Innovative Industrial Properties, Nokia And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Poshmark, Inc. (NASDAQ: POSH) missed the quarter badly when others in that industry are doing quite well,... 
Via Benzinga
Why Are Tandem Diabetes Shares Falling Premarket Today?
Tandem Diabetes Care Inc (NASDAQ: TNDM) reported Q3 sales of $179.6 million, +45% Y/Y, beating the consensus of $171.41 million. The Company posted EPS of $0.09, a... 
Via Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Tandem Diabetes Care, inc (TNDM) Q3 2021 Earnings Call Transcript
TNDM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Tandem Diabetes Care: Q3 Earnings Insights
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:05 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
Tandem Diabetes Care Announces Third Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Third Quarter 2021 Financial Results on November 3, 2021
From Tandem Diabetes Care, Inc.
Via Business Wire
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
Via Benzinga
Tandem Diabetes Care Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance. 
Via Investor's Business Daily
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
Why Tandem Diabetes Care Stock Jumped Today
The stock is being added to the S&P MidCap 400 Index. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
45 Stocks Moving In Tuesday's Mid-Day Session
Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... 
Via Benzinga
This Simple Thing Sent These 3 Nasdaq Stocks Soaring Tuesday
All it takes is money -- big money. 
Via The Motley Fool
Topics Stocks
Exposures COVID-19 US Equities
Match Stock, Tandem Diabetes Lead Big Movers Due To S&P Index Changes
Match will join the S&P 500 and Tandem Diabetes the S&P MidCap 400. UniQure enters the SmallCap 600. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
23 Stocks Moving in Tuesday's Pre-Market Session
Gainers IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares rose 36.6% to $4.37 in pre-market... 
Via Benzinga
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
Tandem Diabetes Care Stock Sees Improved Relative Strength
The Relative Strength (RS) Rating for Tandem Diabetes Care stock moved up into a higher percentile Monday, as it got a lift from 68 to 73. 
Via Investor's Business Daily
Tandem Diabetes Care, inc (TNDM) Q2 2021 Earnings Call Transcript
TNDM earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
Tandem Diabetes Care Announces Second Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.